摘要
放射性核素诊疗一体化为实现精准诊断与治疗分化型甲状腺癌、神经内分泌肿瘤与前列腺癌等恶性肿瘤提供了个体化方案,既带来巨大机遇,也在开发新靶点、研发新型放射性药物、辐射剂量学与安全性评估等方面带来挑战。本文就放射性核素诊疗一体化面临的挑战与机遇进行展望。
The radiotheranostics allows for precise diagnosis and treatment of differentiated thyroid cancer,neuroendocrine tumors,prostate cancer and other malignant diseases through providing solutions for personalized medicine.The development of radiotheranostics owns opportunities but also confronts challenges,including developing novel radiopharmaceuticals with new targets,clinical translation,radiometry and safety assessment.The challenges and opportunities of radiotheranostics were looked in this article.
作者
兰晓莉
宋祥铭
LAN Xiaoli;SONG Xiangming(Department of Nuclear Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Hubei Province Key Laboratory of Molecular Imaging,Key Laboratory of Biological Targeted Therapy,the Ministry of Education,Wuhan 430022,China)
出处
《中国医学影像技术》
CSCD
北大核心
2024年第1期3-6,共4页
Chinese Journal of Medical Imaging Technology
基金
国家自然科学基金(82030052)。
关键词
肿瘤
放射性核素显像
neoplasms
radionuclide imaging
